BEZZIO, Cristina
 Distribuzione geografica
Continente #
AS - Asia 705
NA - Nord America 543
SA - Sud America 192
EU - Europa 148
AF - Africa 19
OC - Oceania 1
Totale 1.608
Nazione #
US - Stati Uniti d'America 512
SG - Singapore 448
BR - Brasile 160
CN - Cina 127
VN - Vietnam 43
IT - Italia 32
HK - Hong Kong 24
DE - Germania 23
IN - India 18
MX - Messico 17
BD - Bangladesh 14
IE - Irlanda 13
FR - Francia 12
GB - Regno Unito 12
CA - Canada 10
FI - Finlandia 10
RU - Federazione Russa 10
AR - Argentina 9
EC - Ecuador 9
NL - Olanda 8
AT - Austria 6
ZA - Sudafrica 5
ES - Italia 4
IQ - Iraq 4
LT - Lituania 4
PE - Perù 4
PY - Paraguay 4
ID - Indonesia 3
IR - Iran 3
JP - Giappone 3
NG - Nigeria 3
PK - Pakistan 3
PL - Polonia 3
TN - Tunisia 3
BE - Belgio 2
CL - Cile 2
CO - Colombia 2
EG - Egitto 2
IL - Israele 2
LV - Lettonia 2
MA - Marocco 2
SA - Arabia Saudita 2
SE - Svezia 2
TR - Turchia 2
UZ - Uzbekistan 2
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
ML - Mali 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
TV - Tuvalu 1
UY - Uruguay 1
Totale 1.608
Città #
Singapore 172
The Dalles 104
Ashburn 60
Shanghai 57
Chandler 43
Beijing 35
Dallas 33
Hong Kong 23
Boardman 20
Los Angeles 19
Milan 16
Santa Clara 15
Hanoi 14
Dublin 13
Ho Chi Minh City 12
Mexico City 12
São Paulo 11
Helsinki 10
Secaucus 9
Düsseldorf 8
Lawrence 8
New York 8
Princeton 8
Brooklyn 7
Buffalo 7
Montreal 7
Seattle 7
London 6
Amsterdam 5
Chennai 5
Rio de Janeiro 5
Rome 5
Munich 4
Porto Alegre 4
Portsmouth 4
Quito 4
San Francisco 4
Belo Horizonte 3
Benin City 3
Brasília 3
Chicago 3
Curitiba 3
Dhaka 3
Irsina 3
Johannesburg 3
Lima 3
Limeira 3
Paris 3
Phoenix 3
São Bernardo do Campo 3
Tokyo 3
Warsaw 3
Asunción 2
Atlanta 2
Boston 2
Bruino 2
Brussels 2
Campinas 2
Caxias do Sul 2
Chandigarh 2
Concord 2
Council Bluffs 2
Cuiabá 2
Foz do Iguaçu 2
Guarulhos 2
Guayaquil 2
Houston 2
Itabira 2
Jacksonville 2
Lambaré 2
Lauterbourg 2
Moscow 2
Ninh Bình 2
Pinhais 2
Pune 2
Raleigh 2
Recife 2
Ribeirão Preto 2
Rio Grande 2
San Jose 2
San Mateo 2
Santa Rosa 2
Stockholm 2
Tashkent 2
Thái Bình 2
Tunis 2
Abidjan 1
Addis Ababa 1
Aguascalientes 1
Aleksandrov 1
Alfredo Vasconcelos 1
Amman 1
Ankara 1
Araraquara 1
Arequipa 1
Babahoyo 1
Baghdad 1
Bagé 1
Baltimore 1
Bamako 1
Totale 911
Nome #
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 80
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors 67
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study 56
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study 49
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 45
Factors correlated with transmural healing in patients with Crohn's disease in long-term clinical remission on anti-TNF medication 44
Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study 42
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 41
Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy 39
Efficacy of a novel self-assembling peptide hemostatic gel as rescue therapy for refractory acute gastrointestinal bleeding 39
Dietary Fiber in Inflammatory Bowel Disease: Are We Ready to Change the Paradigm? 38
The Impact of Ustekinumab Biosimilar on Therapeutic Strategies in Crohn's Disease: A Paradigm Shift? 35
Biologic Therapies May Reduce the Risk of COVID-19 in Patients With Inflammatory Bowel Disease 35
Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor: A multicentre IG‐IBD study 34
Hold the Foam : Why Topical Budesonide Remains Relevant for IBD Therapy 34
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey 33
Reporting of Magnetic Resonance Enterography in Inflammatory Bowel Disease: Results of an Italian Survey 33
Exploring the link: Porto-sinusoidal vascular disorder and inflammatory bowel disease – A comprehensive narrative review 31
The learning curve for using intestinal ultrasonography 30
Impact of histologic disease activity on long-term outcomes in patients with ileal pouch-anal anastomosis for ulcerative colitis 30
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study 30
Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections 29
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study 29
Efficacy and Safety of Adalimumab Biosimilar GP2017 in Patients with Inflammatory Bowel Disease 28
Ophthalmological Manifestations in Inflammatory Bowel Diseases: Keep an Eye on It 28
Eosinophils, Eosinophilic Gastrointestinal Diseases, and Inflammatory Bowel Disease: A Critical Review 28
Noninvasive Assessment of Postoperative Disease Recurrence in Crohn’s Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease 28
Gastrointestinal ultrasound in inflammatory bowel disease: Seeing beyond limits 28
Nutritional care at centres managing patients with inflammatory bowel disease: A nationwide survey in Italy 27
IBD Flare in the COVID-19 Pandemic:Therapy Discontinuation Is to Blame 26
Severe Inflammatory Bowel Disease Flares and COVID-19: Expand the Gastroenterology-Surgery Team to Include an Infectious Disease Specialist 26
Efficacy, safety and tolerability, the imperfect triangle arising from the new low volume colon preparations 24
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus 24
Improvement in appropriateness and diagnostic yield of fast-track endoscopy during the COVID-19 pandemic in Northern Italy 23
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology 23
Artificial intelligence in gastrointestinal endoscopy for inflammatory bowel disease: a systematic review and new horizons 23
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 23
Golimumab improves health-related quality of life of patients with moderate-to-severe ulcerative colitis: Results of the go-care study 23
Prevalence and Clinical Impact of Immune-Mediated Inflammatory Diseases in Patients with Inflammatory Bowel Disease: Results from a Large Retrospective Observational Study 22
Endoscopic ultrasound-guided gallbladder drainage in pancreatic cancer and cholangitis: A case report 22
Ultrasonography Tight Control and Monitoring in Crohn’s Disease During Different Biological Therapies: A Multicenter Study 22
Management of Post-Operative Crohn’s Disease: Knowns and Unknowns 22
Management of proctitis in ulcerative colitis and the place of biological therapies 22
Prevalence, Risk Factors and Association with Clinical Outcomes of Malnutrition and Sarcopenia in Inflammatory Bowel Disease: A Prospective Study 22
Planning phase two for endoscopic units in Northern Italy after the COVID-19 lockdown: An exit strategy with a lot of critical issues and a few opportunities 21
Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy 21
Ulcerative Colitis : not only gut 21
Does ProCore fine needle biopsy really improve the clinical outcome of endoscopic ultrasound-guided sampling of pancreatic masses? 20
Infliximab for severe ulcerative colitis and subsequent SARS-CoV-2 pneumonia: a stone for two birds 20
Clinical Characteristics of COVID-19 Patients With Gastrointestinal Symptoms in Northern Italy: A Single-Center Cohort Study 19
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population 19
Psoriasis and inflammatory bowel disease: concomitant IMID or paradoxical therapeutic effect? A scoping review on anti-IL-12/23 and anti-IL-23 antibodies 18
Immune-Mediated Inflammatory Diseases Awareness and Management among Physicians Treating Patients with Inflammatory Bowel Disease: An IG-IBD Survey 17
Inflammatory bowel disease in a colorectal cancer screening population: Diagnosis and follow-up 16
Proposal for returning to routine endoscopy during the COVID-19 pandemic: what is really feasible? 15
Upadacitinib in Patients With Difficult-to-Treat Crohn’s Disease 14
Neuroendocrine tumors in patients with inflammatory bowel disease: a case series 7
A multicenter study on bowel preparation in inflammatory bowel disease patients: comparison between 1L-PEG-ASC and 2L-PEG regimens in an outpatient setting 2
Attitudes of physicians managing inflammatory bowel disease toward alterations of liver function tests: an Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) survey 2
Totale 1.669
Categoria #
all - tutte 11.447
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.447


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 1 0 1 1 0 1
2021/20226 0 0 0 1 0 0 0 0 1 0 3 1
2022/2023107 17 2 9 16 8 13 0 7 16 10 7 2
2023/2024156 3 7 20 5 2 5 8 4 0 34 29 39
2024/2025703 6 7 20 15 6 43 46 66 125 164 100 105
2025/2026693 217 90 68 153 118 47 0 0 0 0 0 0
Totale 1.669